Type 1 diabetes (T1D) and multiple sclerosis

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
Petr75
Family Elder
Posts: 642
Joined: Sat Oct 19, 2013 10:17 am
Location: Czech Republic

Type 1 diabetes (T1D) and multiple sclerosis

Post by Petr75 » Thu Jan 09, 2020 4:23 am

2020 Jan 7
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
Identification of common key genes and pathways between type 1 diabetes and multiple sclerosis using transcriptome and interactome analysis.
https://www.ncbi.nlm.nih.gov/pubmed/31912409

Abstract
PURPOSE:
Type 1 diabetes (T1D) and multiple sclerosis (MS) are classified as T cell-mediated autoimmune diseases. Although convergent evidence proposed common genetic architecture for autoimmune diseases, it remains a challenge to identify them. This study aimed to determine common gene signature and pathways in T1D and MS via systems biology approach.
METHODS:
Gene expression profiles of peripheral blood mononuclear cells (PBMCs) and pancreatic-β cells in T1D as well as PBMCs and cerebrospinal fluid (CSF) in MS were analyzed in our previous published data, and differential expressed genes were integrated with protein-protein interactions data to construct Query-Query PPI (QQPPI) networks. In this study, QQPPI networks were further analyzed to investigate more central genes, functional modules and complexes shared in T1D and MS progression. Lastly, the interaction of common genes with drugs was also explored.
RESULTS:
Several cytokines such as IL-23A, IL-32, IL-34, and IL-37 tend to be differentially expressed in both diseases. In addition, PSMA1, MYC, SRPK1, YBX1, HNRNPM, NF-κB2, IKBKE, RAC1, FN1, ARRB2, ESR1, HSP90AB1, and PPP1CA were common high central genes in QQPPI networks corresponding to each disease. Proteasome, spliceosome, immune responses, apoptosis, cellular communication/signaling transduction mechanism, interaction with environment, and activity of intercellular mediators were shared biological processes in T1D and MS. Finally, azathioprine, melatonin, resveratrol, and geldanamycin identified as prioritized drugs for the treatment of patients with T1D and MS.
CONCLUSIONS:
This study represented novel key genes and pathways shared between T1D and MS, which may facilitate the identification of potential therapeutic targets in these diseases.

User avatar
frodo
Family Elder
Posts: 1400
Joined: Wed Dec 02, 2009 3:00 pm
Contact:

Re: Type 1 diabetes (T1D) and multiple sclerosis

Post by frodo » Wed Jan 15, 2020 4:02 am

It is interesting thay they recommend different drugs than for normal MS (azathioprine, melatonin, resveratrol, and geldanamycin). They sound safer than the normal MS drugs.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post